Imperva Inc (IMPV) Expected to Announce Quarterly Sales of $86.40 Million
Brokerages forecast that Imperva Inc (NASDAQ:IMPV) will post sales of $86.40 million for the current quarter, Zacks reports. Four analysts have provided estimates for Imperva’s earnings, with the highest sales estimate coming in at $87.30 million and the lowest estimate coming in at $85.80 million. Imperva reported sales of $72.31 million in the same quarter last year, which indicates a positive year over year growth rate of 19.5%. The business is scheduled to issue its next quarterly earnings report on Thursday, May 3rd.
On average, analysts expect that Imperva will report full year sales of $86.40 million for the current year, with estimates ranging from $372.00 million to $383.00 million. For the next financial year, analysts expect that the company will post sales of $433.41 million per share, with estimates ranging from $422.00 million to $439.90 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Imperva.
Imperva (NASDAQ:IMPV) last released its quarterly earnings results on Thursday, February 8th. The software maker reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.13. The business had revenue of $91.10 million during the quarter, compared to analysts’ expectations of $91.11 million. Imperva had a negative return on equity of 3.37% and a net margin of 7.11%. The company’s revenue was up 16.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.32 EPS.
Imperva (NASDAQ:IMPV) traded up $4.50 during midday trading on Thursday, hitting $46.55. The stock had a trading volume of 2,140,000 shares, compared to its average volume of 343,454. The stock has a market cap of $1,580.00, a PE ratio of 69.48 and a beta of 1.79. Imperva has a fifty-two week low of $37.17 and a fifty-two week high of $52.40.
Institutional investors and hedge funds have recently bought and sold shares of the stock. SG Americas Securities LLC acquired a new position in Imperva during the 3rd quarter worth about $134,000. First Quadrant L P CA acquired a new position in Imperva during the 3rd quarter worth about $136,000. Ameritas Investment Partners Inc. raised its position in Imperva by 18.7% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,940 shares of the software maker’s stock valued at $141,000 after purchasing an additional 464 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. raised its position in Imperva by 26.2% in the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 4,177 shares of the software maker’s stock valued at $201,000 after purchasing an additional 866 shares in the last quarter. Finally, Amalgamated Bank acquired a new stake in Imperva in the 2nd quarter valued at about $206,000. 96.61% of the stock is currently owned by hedge funds and other institutional investors.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.